Tavexia Lifecare Board Approves Auditor Transition and Acquisition of Meyonex Pharmaceuticals
Sattva Sukun Lifecare Ltd 路 Change in Auditor 路 08 Sept 2026, 12:54 am
Tavexia Lifecare Board Approves Auditor Transition and Acquisition of Meyonex Pharmaceuticals Tavexia Lifecare's board approved the resignation of statutory auditor M/s SSRV & Associates and appointed M/s DEVAM & Associates LLP for a five-year term starting FY27, subject to shareholder approval at the 46th AGM. The board also authorized preliminary due diligence and negotiations to acquire up to a 60% equity stake in unlisted Meyonex Pharmaceuticals Ltd, which has a paid-up capital of Rs 13.998 cr. Additionally, the re-appointment of Khushboo Vasudev as Independent Director for a second five-year term was approved.
Original exchange filing (PDF)
More announcements from Sattva Sukun Lifecare Ltd
- Financial Result 路 05 Nov 2026
- Announcement 路 05 Nov 2026
- Board has Approved in Change in RTA 路 05 Nov 2026
- Result 路 05 Nov 2026
- Outcome of Board Meeting 路 05 Nov 2026
- Tavexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting 路 04 Nov 2026
- Announcement 路 13 Oct 2026
- Disclosure under regulation 30 路 12 Oct 2026
